Tocilizumab Stumbles as COVID-19 Treatment, Narrow Role Possible
New randomized controlled trial data show tocilizumab has a narrow role at best for treating COVID-19.
New randomized controlled trial data show tocilizumab has a narrow role at best for treating COVID-19.
Erenumab was more effective than oral preventive medications in reducing migraine days with better patient adherence and satisfaction.
Reminders sent via text message or patient portal did not increase rates of influenza vaccination.
Listen to the experts as they share the latest findings on HER2-directed therapies in the treatment of HER2-positive metastatic colorectal cancer (mCRC).
Join Drs Ibiayi Dagogo-Jack and Joshua Sabari on social media as they explore the latest therapeutic strategies for early-stage, resectable NSCLC.
Can you separate fact from fiction when it comes to PROS? Test your knowledge with this quiz.
This summary of NICE’s guideline covers how to make shared decision making part of everyday care in secondary healthcare settings
The size of the human brain has increased over time, a new finding that may help explain a previously reported decline in incident dementia.
PROS is a group of rare congenital disorders characterized by overgrowth ranging from isolated digits to whole limbs and beyond. What conditions are in the…
Patients with advanced EGFR-mutated NSCLC who were given osimertinib plus chemotherapy up front continue to show improved outcomes after initial progression, suggests ongoing trial data.
San Diego Mission Bay Resort San Diego, California For 27 years, the Acute Leukemia Forum (ALF) has provided a unique platform that enables the world’s…